These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 9553319)
1. The application of GnRH analogues in the treatment of uterine myomas in perimenopausal women. Dragojević-Dikić S; Vućić M Ginekol Pol; 1998 Jan; 69(1):28-33. PubMed ID: 9553319 [TBL] [Abstract][Full Text] [Related]
2. Prolapsed leiomyoma with severe haemorrhage after GnRH analogue therapy. Kriplani A; Agarwal N; Parul D; Bhatla N; Saxena AK J Obstet Gynaecol; 2002 Jul; 22(4):449-51. PubMed ID: 12521484 [No Abstract] [Full Text] [Related]
3. Use of a gonadotropin-releasing hormone agonist to manage perimenopausal women with symptomatic uterine myomas. Wang PH; Lee WL; Cheng MH; Yen MS; Chao KC; Chao HT Taiwan J Obstet Gynecol; 2009 Jun; 48(2):133-7. PubMed ID: 19574174 [TBL] [Abstract][Full Text] [Related]
4. A prospective, randomized trial of gonadotropin-releasing hormone agonist plus estrogen-progestin or progestin "add-back" regimens for women with leiomyomata uteri. Friedman AJ; Daly M; Juneau-Norcross M; Rein MS; Fine C; Gleason R; Leboff M J Clin Endocrinol Metab; 1993 Jun; 76(6):1439-45. PubMed ID: 8501148 [TBL] [Abstract][Full Text] [Related]
7. Quantitative MRI of uterine leiomyomas during triptorelin treatment: reproducibility of volume assessment and predictability of treatment response. Broekmans FJ; Heitbrink MA; Hompes PG; Schoute E; Falke T; Schoemaker J Magn Reson Imaging; 1996; 14(10):1127-35. PubMed ID: 9065902 [TBL] [Abstract][Full Text] [Related]
8. The hemodynamic effect of GnRH agonist therapy on uterine leiomyoma vascularity: a prospective study using transvaginal color Doppler sonography. Aleem FA; Predanic M Gynecol Endocrinol; 1995 Sep; 9(3):253-8. PubMed ID: 8540296 [TBL] [Abstract][Full Text] [Related]
9. Three-month treatment with triptorelin, letrozole and ulipristal acetate before hysteroscopic resection of uterine myomas: prospective comparative pilot study. Bizzarri N; Ghirardi V; Remorgida V; Venturini PL; Ferrero S Eur J Obstet Gynecol Reprod Biol; 2015 Sep; 192():22-6. PubMed ID: 26142912 [TBL] [Abstract][Full Text] [Related]
10. Short-term and long-term results of resectoscopic myomectomy with and without pretreatment with GnRH analogs in premenopausal women. Campo S; Campo V; Gambadauro P Acta Obstet Gynecol Scand; 2005 Aug; 84(8):756-60. PubMed ID: 16026401 [TBL] [Abstract][Full Text] [Related]
11. The combined effect of a GnRH analog in premenopause plus postmenopausal estrogen deficiency for the treatment of uterine leiomyomas in perimenopausal women. de Aloysio D; Altieri P; Pretolani G; Romeo A; Paltrinieri F Gynecol Obstet Invest; 1995; 39(2):115-9. PubMed ID: 7737580 [TBL] [Abstract][Full Text] [Related]
12. [Analogs of gonadoliberin in the treatment of endometriosis and uterine myoma. Comparison of daily subcutaneous treatment and intramuscular depot therapy]. Horský J; Cerný M; Dvorák P; Lepová B; Zizkovský V; Vondrácek J Cesk Gynekol; 1989 Aug; 54(7):486-95. PubMed ID: 2529980 [TBL] [Abstract][Full Text] [Related]
13. [Laparoscopic myomectomy: preparation for procedure and operation technique]. Reroń A; Trojnar-Podleśny M Ginekol Pol; 2003 Dec; 74(12):1578-84. PubMed ID: 15029753 [TBL] [Abstract][Full Text] [Related]
14. Uterine leiomyomata and sterility: therapy with gonadotropin-releasing hormone agonists and leiomyomectomy. Kuhlmann M; Gärtner A; Schindler EM; Regidor PA; Bühler K; Schindler AE Gynecol Endocrinol; 1997 Jun; 11(3):169-74. PubMed ID: 9209897 [TBL] [Abstract][Full Text] [Related]
15. [Treatment of uterine leiomyoma with depot leuprorelin acetate (Enantone-Gyn monthly depot). Effect on leiomyoma volume and operability. German Leuprorelin Study Group]. Stolz W; Pfützenreuter N Zentralbl Gynakol; 1997; 119(10):468-75. PubMed ID: 9432825 [TBL] [Abstract][Full Text] [Related]
16. [GnRH analogues and myomas: which strategy?]. Poncelet C Gynecol Obstet Fertil; 2005 Dec; 33(12):1018. PubMed ID: 16316770 [No Abstract] [Full Text] [Related]
17. [GnRH-analogs in the therapy of uterine myomatosis]. Wieacker P; Geisthövel F; Adelberger V; Breckwoldt M Ther Umsch; 1990 Dec; 47(12):951-7. PubMed ID: 2151405 [TBL] [Abstract][Full Text] [Related]
18. Medical treatment of uterine myoma with long-acting gonadotropin-releasing hormone agonist prior to myomectomy. Liu CH; Lin YS; Lin CC; Tzeng CC; Chou CY J Formos Med Assoc; 1993 Jun; 92(6):536-9. PubMed ID: 8106041 [TBL] [Abstract][Full Text] [Related]
19. Long-term use of an LH-RH agonist in the management of uterine leiomyomas: a study of 17 cases. George M; Lhomme C; Lefort J; Gras C; Comaru-Schally AM; Schally AV Int J Fertil; 1989; 34(1):19-24. PubMed ID: 2565299 [TBL] [Abstract][Full Text] [Related]
20. Transient shrinkage of a uterine leiomyosarcoma treated with GnRH agonist for a presumed uterine leiomyoma: comparison of magnetic resonance imaging finding before and during GnRH agonist treatment. Kawamura N; Iwanaga N; Hada S; Maeda K; Sumi T; Ishiko O; Ogita S Oncol Rep; 2001; 8(6):1255-7. PubMed ID: 11605044 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]